How Pharma Is Preparing For a Post COVID World

How Pharma Is Preparing For a Post COVID World

Pharma in the Post-COVID Era Prescient’s industry snapshot points the direction of change for pharma businesses JULY 2020 Dr. Nick TurnerSenior Director COVID-19 has propelled the pharma industry onto the front pages with the desperate search for a vaccine. Below the...
Winning responses to the impact of COVID-19

Winning responses to the impact of COVID-19

Winning responses to the impact of COVID-19 Prescient’s thought leaders address major shifts in the landscape and outline near-, medium- and long-term choices facing pharma strategy leaders JUNE 2020 Dr. Debashish TalukdarGlobal Head of Advisory at Prescient...
Maximizing Insights from Virtual Conferences

Maximizing Insights from Virtual Conferences

Maximizing Insights from Virtual Conferences Content and offerings are evolving – so should your approach to maximize insights APRIL 2020 Ben Doran, MScVice President Tanya Casimiro, PhDEngagement Manager As conference organizers still have their missions to educate,...
CAR-T: Advancing the Path for Clinical and Commercial Success

CAR-T: Advancing the Path for Clinical and Commercial Success

By: Ben Doran, Stuart Crichton, Ben Druck and Vasiliki Patsioura.The Prescient team has prepared a white paper discussing our view on the recent advances in the CAR-T landscape. In this paper, we do not focus on the already well-documented challenges, but rather...